<br />
REPRODUCTIVE<br />
HEALTH<br />
EMJ Repro Health. 2019 Suppl 3 • europeanmedical-journal.com<br />
INSIDE<br />
Assisted Reproductive<br />
Technologies Across<br />
a Heterogeneous<br />
Patient Population<br />
Assisted Reproductive Technologies Across a<br />
Heterogeneous Patient Population<br />
This symposium took place on Tuesday 25th June 2019 as part<br />
of the European Society of Human Reproduction and Embryology<br />
(ESHRE) annual meeting in Vienna, Austria.<br />
Chairpeople: Marco Filicori (Italy),1 Joop Laven (The Netherlands)2<br />
Speakers: Valerie Baker (USA),3 Nick Raine-Fenning (UK),4,5 Pauline Wijngaard-<br />
Boom (The Netherlands)6<br />
1. Reproductive Medicine Unit, GynePro Medical Group, Bologna, Italy<br />
2. Division of Reproductive Medicine, Department of Obstetrics and Gynecology,<br />
Erasmus MC, Rotterdam, The Nether<a title="EMJ Repro Health 2019 Suppl 3 page 1" href="http://viewer.zmags.com/publication/ed6d9faa?page=1"> REPRODUCTIVE HEALTH EMJ Repro Health. 2019 Suppl</a>
<a title="EMJ Repro Health 2019 Suppl 3 page 2" href="http://viewer.zmags.com/publication/ed6d9faa?page=2"> Assisted Reproductive Technologies Across a </a>
<a title="EMJ Repro Health 2019 Suppl 3 page 3" href="http://viewer.zmags.com/publication/ed6d9faa?page=3"> highly purified human menopausal gonadotrophin (HP</a>
<a title="EMJ Repro Health 2019 Suppl 3 page 4" href="http://viewer.zmags.com/publication/ed6d9faa?page=4"> Unexplained Uterine infertility </a>
<a title="EMJ Repro Health 2019 Suppl 3 page 5" href="http://viewer.zmags.com/publication/ed6d9faa?page=5"> models can be applied to observational data and c</a>
<a title="EMJ Repro Health 2019 Suppl 3 page 6" href="http://viewer.zmags.com/publication/ed6d9faa?page=6"> HP-hMG rFSH Ongoing pregnancy rate (%) 30 27 </a>
<a title="EMJ Repro Health 2019 Suppl 3 page 7" href="http://viewer.zmags.com/publication/ed6d9faa?page=7"> Due to the distinct properties of follitropin del</a>
<a title="EMJ Repro Health 2019 Suppl 3 page 8" href="http://viewer.zmags.com/publication/ed6d9faa?page=8"> OS cycles, with advantages observed mainly i</a>
<a title="EMJ Repro Health 2019 Suppl 3 page 9" href="http://viewer.zmags.com/publication/ed6d9faa?page=9"> 7. Gershman B et al. Using observational 15</a>